# K223609: RevCore™ Thrombectomy Catheter.

- Pathway: 510(k) (Traditional)
- Applicant: Inari Medical, Inc.
- Decided: Mar 14, 2023 after 102 days
- Product code: QEW (Peripheral Mechanical Thrombectomy With Aspiration)
- Device class: 2
- Regulation: 21 CFR 870.5150
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 17 generations back to K901627 (1990). 26 ancestors in all.
2 later devices descend from it; 2 cite it directly.
0 of 29 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K212632: ClotTriever Thrombectomy System, Inari Medical, Inc. (2021) Summary page 4.

## Most influential descendants
- K251185: Recana Thrombectomy Catheter System (FG014. FG015, FG016, FG017, FG018, FG019, FG020) (2025), 0 descendants of its own
- K234034: VenaCore Thrombectomy Catheter (46-101) (2024), 0 descendants of its own

## Indications for use
The RevCore Thrombectomy Catheter is indicated for: * The non-surgical removal of thrombi and emboli from blood vessels. * Injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The RevCore Thrombectomy Catheter is intended for use in the peripheral vasculature system

Source page: https://510kreport.com/device/K223609
Methodology: https://510kreport.com/methodology